E. Regañón
E. Regañón publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology, on topics such as Blood properties and coagulation, Diabetes, Cardiovascular Risks, and Lipoproteins and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #6,440,959 of 7,710,434 ranked researchers
- Rank in Spain
- #158,179 of 204,306
- Works
- 45
- Citations
- 488
- Citations per work
- 10.8
What does E. Regañón research?
E. Regañón's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2555.8%
- Medicine2555.8%
- Everything else1634.7%
- Life Sciences49.5%
- 1Pulmonary and Respiratory Medicine22% of their works
- 2Cardiology and Cardiovascular Medicine14% of their works
- 3Molecular Biology10% of their works
- 4Endocrinology, Diabetes and Metabolism8% of their works
- 5Transplantation6% of their works
- 6Surgery5% of their works
Research topics
- Blood properties and coagulation
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Antiplatelet Therapy and Cardiovascular Diseases
- Transplantation: Methods and Outcomes
- Protease and Inhibitor Mechanisms
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Blood Coagulation and Thrombosis Mechanisms
Which keywords describe E. Regañón's research?
The keywords of their largest research topics: Hemostasis, Fibrinogen, Transglutaminases, Cardiovascular Disease, Diabetes, Guidelines, Metabolic Syndrome and Aspirin.
- Thrombin
- Myocardial Infarction
- Atrial Fibrillation
- Acute Coronary Syndromes
- Rejection
- Aspirin
- Guidelines
- Cardiovascular Disease
- Fibrinogen
- Hemostasis
- Transglutaminases
- Diabetes
- Metabolic Syndrome
- Clopidogrel
- Transplantation
- Anticoagulant Therapy
- Matrix Metalloproteinases
- Protease-Activated Receptors
- Tissue Inhibitors of Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Hemostasis242 topics
- Fibrinogen211 topic
- Transglutaminases211 topic
- Cardiovascular Disease92 topics
- Diabetes61 topic
- Guidelines62 topics
- Metabolic Syndrome61 topic
- Aspirin41 topic
- Clopidogrel41 topic
- Rejection41 topic
- Transplantation41 topic
- Acute Coronary Syndromes31 topic
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Matrix Metalloproteinases31 topic
- Myocardial Infarction31 topic
- Protease-Activated Receptors31 topic
- Thrombin31 topic
- Tissue Inhibitors of Metalloproteinases31 topic
Where does E. Regañón work?
E. Regañón's main affiliation in the publication record is Hospital Universitari i Politècnic La Fe, Spain.
How many publications and citations does E. Regañón have?
OpenAlex counts 45 works and 488 citations for E. Regañón, an h-index of 12, ranking #6,440,959 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about E. Regañón. Posts are plain text and can be reported.